Suppression of GCH1 Sensitizes Ovarian Cancer and Breast Cancer to PARP Inhibitor

Figure 1

GCH1 was upregulated in niraparib-treated groups. (a) Heatmap and (b) volcano plots of differentially expressed metabolism-related genes under niraparib administration.

(a)

(b)